HA PEGylated Filler in Association with an Infrared Energy Device for the Treatment of Facial Skin Aging: 150 Day Follow-Up Data Report

Paweł Kubik,Jerzy Jankau,Raffaele Rauso,Hassan Galadari,Marina Protasoni,Wojciech Gruszczyński,Dariusz Grzanka,Marta Smolińska,Paulina Antosik,Maria-Luiza Piesiaków,Lidia Kodłubańska,Anna Zagajewska,Bartłomiej Łukasik,Giorgio Stabile,Nicola Zerbinati
DOI: https://doi.org/10.3390/ph15111355
IF: 4.6
2022-11-03
Pharmaceuticals
Abstract:Background: The face is the area most exposed to the normal course of skin aging, both intrinsically and extrinsically. The aim of the study was to evaluate the cellular and clinical response of a therapeutic protocol aimed at countering facial skin aging. Materials and Methods: Twenty female patients with facial skin laxity and photodamage underwent combined therapy including mesotherapy using non-cross-linked hyaluronic acid with calcium hydroxyapatite and an infrared energy-based device treatment with subsequent implementation of PEG-cross-linked hyaluronic acid soft tissue fillers. To evaluate the benefits, patients underwent histological, immunological, and biomechanical evaluations before the treatment and at 21 and 150 days after the treatment. Results: The histological results at 21 days and 150 days after the procedure showed an increase in the number of fibroblasts and angiogenesis. As for the immunological aspect, it was shown that the treatment has an immunomodulating action, avoiding the activation of CD4 and CD8 cells. Biomechanical data showed that, at 150 days after treatment, the average changes in skin elasticity increased by 72% and the skin hydration increased by 49%. Conclusions: A combination of an infrared energy-based device treatment with both non-cross-linked hyaluronic acid and novel PEG-cross-linked hyaluronic acid leads to numerous positive cutaneous changes after histological, immunological, and biomechanical evaluations.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?